Sexual dimorphism of neonatal lung development

L Gortner1, J Shen2, E Tutdibi1

  • 1Department of Pediatrics, Neonatology, University of the Saarland, Homburg, Germany.

Klinische Padiatrie
|March 26, 2013
PubMed

Insights

Female infants show better neonatal lung development and outcomes due to estrogen effects. This research explains why females have improved lung health, particularly in early development and survival rates.

Area of Science:

  • Reproductive biology
  • Neonatal physiology
  • Pulmonary medicine

Background:

  • Studies report gender disparities in neonatal survival and short-term pulmonary outcomes.
  • Females exhibit better outcomes in childhood chronic lung disorders.

Purpose of the Study:

  • To review published data on gender differences in lung development.
  • To elucidate the biological mechanisms underlying sex-based variations in lung maturation and disease susceptibility.

Main Methods:

  • A comprehensive literature survey was conducted on existing research concerning sex-based differences in lung development.
  • Analysis focused on genetic regulation, functional maturation, and the impact of pregnancy complications.

Main Results:

  • Estrogen, mediated by estrogen receptor beta (ER-β), influences gene expression (e.g., VEGF, PDGF) crucial for early lung development in females.
  • Estrogens positively regulate surfactant protein synthesis, enhancing female lung maturation.
  • Females exhibit larger lung volumes under inflammatory conditions (LPS), though gender's effect on intrauterine growth restriction prognosis is less clear.

Conclusions:

  • Experimental findings support epidemiological data showing poorer male prognosis in neonatal lung disorders.
  • Elevated estrogen levels in females, acting through ER-β, are a key factor in improved female lung development and outcomes.
Abstract